Sarcoma  >>  rebimastat (BMS-275291)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
rebimastat (BMS-275291) / BMS
NCT00024024: BMS-275291 in Treating Patients With HIV-Related Kaposi's Sarcoma

Completed
1/2
59
US
rebimastat
National Cancer Institute (NCI)
Sarcoma
08/03
 

Download Options